Understanding how engineered nanoparticles interact with kidney cells
Unravel Nanoparticle Transport and Interactions in Renal Proximal Tubules
This study is looking at how tiny particles used in medicine move and interact with kidney cells, which are important for filtering waste, to help make sure these particles are safe and effective for people with kidney issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Dallas NIH-funded |
| Lab location | 1 site (Richardson, United States) |
| Project ID | NIH-10813800 on NIH RePORTER |
What this research studies
This research investigates how engineered nanoparticles are transported and interact with renal proximal tubule cells, which play a crucial role in filtering and reabsorbing substances in the kidneys. The study aims to explore the effects of size, charge, and surface chemistry of these nanoparticles on their behavior in both healthy and injured kidney tissues. By conducting experiments to analyze these interactions, the research seeks to provide insights that could improve the safety and efficacy of nanomedicines used in clinical settings. The findings could help in developing strategies to minimize potential health risks associated with these nanoparticles.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals undergoing treatments that involve engineered nanoparticles, particularly those with kidney-related conditions.
Not a fit: Patients with no exposure to engineered nanoparticles or those with healthy kidney function may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective use of nanomedicines in treating various conditions.
How similar studies have performed: Previous research has shown promise in understanding nanoparticle interactions in other organ systems, but this specific focus on renal proximal tubules is relatively novel.
Where this research is happening
Richardson, United States
- University of Texas Dallas — Richardson, United States (Active)
Researchers
- Principal investigator: Yu, Mengxiao — University of Texas Dallas
- Study coordinator: Yu, Mengxiao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.